-
Darapladib is an
inhibitor of lipoprotein-****ociated
phospholipase A2 (Lp-PLA2) that is in
development as a drug for
treatment of atherosclerosis. It was...
-
lupus drug
Belimumab (Benlysta),
albiglutide for type 2 diabetes, and
darapladib for atherosclerosis, and in September, sold its
beverage division to Suntory...
- as a
possible therapeutic target (see, e.g. the
investigational drug
Darapladib). In
human atherosclerotic lesions, 2 main
sources of Lp-PLA2 can be identified...
-
dapitant (INN)
dapoxetine (INN)
dapsone (INN)
daptomycin (INN)
Daranide darapladib (USAN, INN)
daratumumab (INN)
Daraprim darbepoetin alfa (INN) Darbid....
- 2012, HGS's
pipeline consisted of six products:
Benlysta Raxiba****ab
Darapladib Albiglutide Mapatumumab HGS1036 The
Disappointment Gene: Why genetics...
-
SmithKline exclusive rights to
Albiglutide for the
treatment of diabetes, and
Darapladib for the
treatment of
coronary artery disease, both were in late stage...
